You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 16, 2025

Drug Price Trends for NDC 66758-0238


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 66758-0238

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
No data available in table
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 0 to 0 of 0 entries

Market Analysis and Price Projections for the Drug NDC: 66758-0238

Understanding the NDC Directory

To analyze the market and price projections for a specific drug identified by its National Drug Code (NDC), it is crucial to understand what the NDC Directory provides. The FDA's National Drug Code Directory contains comprehensive information on finished, unfinished, and compounded drug products, including their NDC numbers, product types, non-proprietary names, dosage forms, routes of administration, and marketing dates[5].

Identifying the Drug

The NDC 66758-0238 is a unique identifier for a specific drug product. To proceed with the analysis, one must first identify the drug associated with this NDC.

Drug Details

While the specific details of the drug with NDC 66758-0238 are not provided in the sources, we can infer how to find and analyze such information:

  • Search the NDC Directory: The FDA's NDC Directory can be searched using the NDC number to find details such as the proprietary name, non-proprietary name, dosage form, route of administration, and labeler name[1][5].
  • Example: For a drug like Eliquis (NDC numbers vary), the directory would provide information on its product type, strength, package code, and package description.

Market Analysis

Market Trends

The pharmaceutical market is undergoing significant changes driven by technological advancements, regulatory shifts, and evolving patient needs.

  • AI and Gene Editing: These technologies are accelerating drug development, reducing costs, and speeding up the time from lab to market. By 2025, AI is expected to be an essential partner in research labs, enhancing the efficiency and accuracy of drug development[3].
  • Immunotherapies and Targeted Therapies: In specific markets like Non-Small Cell Lung Cancer (NSCLC), immunotherapies and targeted therapies are driving growth. Drugs like Keytruda, Opdivo, and Tecentriq are projected to achieve blockbuster status by 2025[4].

Competitive Landscape

To analyze the market for a specific drug, one must consider the competitive landscape:

  • Competitor Drugs: Identify other drugs in the same therapeutic class and their market performance. For instance, in the NSCLC market, the competition includes Keytruda, Opdivo, and Tecentriq[4].
  • Generic and Biosimilar Impact: The entry of generic or biosimilar versions can significantly impact the market share and pricing of branded drugs. For example, the patent expiration of Tarceva and Alimta has led to a decline in their sales and an increase in generic sales[4].

Price Projections

Pricing Factors

Several factors influence the pricing of pharmaceuticals:

  • Regulatory Environment: Changes in regulatory policies can affect drug pricing. For instance, stricter rules about patient data and drug safety may impact pricing strategies[3].
  • Market Demand: The demand for a drug, driven by its efficacy, safety profile, and patient needs, plays a crucial role in pricing.
  • Competition: The presence of competitor drugs, especially generics or biosimilars, can drive prices down.
  • Economic Conditions: Economic factors such as inflation, healthcare policies, and reimbursement rates can also influence drug prices.

Example Pricing Analysis

In the NSCLC market, the prices of immunotherapies and targeted therapies are expected to remain high due to their efficacy and the lack of significant generic competition until 2025. For example:

  • Keytruda: Projected to contribute $5.2 billion in sales by 2025, with a moderate CAGR[4].
  • Generic Impact: The sales of generic versions of drugs like erlotinib and pemetrexed are expected to grow but will not significantly impact the overall market size until 2025[4].

Specific Drug Analysis

Without the specific details of the drug associated with NDC 66758-0238, here is a general approach to analyzing its market and price projections:

  • Identify the Drug: Use the NDC Directory to find the proprietary name, non-proprietary name, and other relevant details.
  • Market Research: Conduct market research to understand the competitive landscape, patient demand, and regulatory environment.
  • Pricing Trends: Analyze pricing trends for similar drugs in the same therapeutic class.
  • Forecasting: Use historical data and market trends to forecast future prices, considering factors like competition, regulatory changes, and economic conditions.

Key Takeaways

  • NDC Directory: A crucial resource for identifying and analyzing drug products.
  • Market Trends: Technological advancements, regulatory shifts, and evolving patient needs are reshaping the pharmaceutical market.
  • Competitive Landscape: Understanding competitor drugs and their market performance is essential for pricing strategies.
  • Pricing Factors: Regulatory environment, market demand, competition, and economic conditions all influence drug pricing.

FAQs

Q: What is the NDC Directory, and how is it used? A: The NDC Directory is a database maintained by the FDA that contains information on finished, unfinished, and compounded drug products. It is used to identify and analyze drug products using their unique NDC numbers.

Q: How does AI impact drug development? A: AI accelerates drug development by analyzing vast datasets, predicting molecular structure changes, and reducing costs and time from lab to market.

Q: What are the key trends in the pharmaceutical industry by 2025? A: Key trends include the use of AI, gene editing, cell therapies, and digital tools. Personalized medicine and sustainable practices are also becoming more prominent.

Q: How do generic and biosimilar drugs affect market prices? A: The entry of generic or biosimilar versions can significantly reduce the market share and prices of branded drugs due to increased competition.

Q: What factors influence the pricing of pharmaceuticals? A: Pricing is influenced by regulatory environment, market demand, competition, and economic conditions.

Sources

  1. YouTube - NDC Directory (March 2015)
  2. Missouri Specialty MAC List (January 2023)
  3. Laboratorios Rubio - The Future of Pharma: 2025's Key Trends To Know
  4. Drug Development - NSCLC Market Global Drug Forecast & Market Analysis to 2025
  5. FDA - National Drug Code Directory (November 2024)

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.